Mark Hall, M.D.
NPI 1609815166 · Dermatology Physician · Bend, OR
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Hall, M.D. is a Dermatology Physician provider in Bend, OR (NPI 1609815166).
Provider details
- NPI number
- 1609815166
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- MD26648 (OR)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
20 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
8,107 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,770 | $7 |
| Ultrasonic Guidance for Placement of Radiation Therapy FieldsG6001 | 1,119 | $180 |
| Obtaining Data Needed to Develop the Optimal Radiation Treatment, 1 Treatment Area77280 | 1,046 | $270 |
| Superficial And/Or Low Voltage Radiation Treatment Delivery77401 | 1,014 | $42 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 481 | $47 |
| Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305 | 455 | $37 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Betamethasone Dipropionate | 63 | 39 |
| Fluorouracil | 49 | 46 |
| Desonide | 34 | 27 |
| Triamcinolone Acetonide | 34 | 25 |
| Metronidazole | 29 | 23 |
| Doxycycline Monohydrate | 21 | — |
| Ketoconazole | 20 | 13 |
| Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-06
- Last updated
- 2013-02-21
Frequently asked questions
- What is Mark Hall's NPI number?
- Mark Hall's National Provider Identifier (NPI) is 1609815166, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Hall's specialty?
- Mark Hall is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Mark Hall located?
- Mark Hall's practice location on file with NPPES is 388 Sw Bluff Dr, Bend, OR 97702-1360.
- What is Mark Hall's phone number?
- The practice phone number listed in the NPPES registry for Mark Hall is (541) 678-0020.
- Does Mark Hall accept Medicare?
- Mark Hall is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Hall's NPI active?
- Yes — Mark Hall's NPI (1609815166) is active in the NPPES registry as of the last update on 2013-02-21.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.